Atlas Capital Advisors LLC now owns 935 shares of the company’s stock valued at $42,000 after acquiring an additional 275 shares during the period. Atlas Capital Advisors LLC lifted its holdings in shares of 10x Genomics by 41.7% during the second quarter. Ltd bought a new position in shares of 10x Genomics during the first quarter valued at $39,000. National Bank of Canada FI now owns 611 shares of the company’s stock valued at $34,000 after acquiring an additional 505 shares during the period. National Bank of Canada FI lifted its holdings in shares of 10x Genomics by 476.4% during the first quarter. Hedge funds and other institutional investors have recently bought and sold shares of the company. According to, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $56.50. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. Finally, Stifel Nicolaus raised their price objective on shares of 10x Genomics from $57.00 to $68.00 in a research note on Thursday, May 4th. They issued an “overweight” rating and a $65.00 price objective on the stock. Barclays initiated coverage on shares of 10x Genomics in a research note on Wednesday, May 10th. They set an “overweight” rating and a $65.00 price target on the stock. Stephens initiated coverage on 10x Genomics in a report on Thursday, March 30th. Several brokerages have commented on TXG. will post -1.42 EPS for the current fiscal year. On average, research analysts forecast that 10x Genomics, Inc. During the same period last year, the business earned ($0.38) earnings per share. The firm’s revenue for the quarter was up 17.3% compared to the same quarter last year. 10x Genomics had a negative return on equity of 22.02% and a negative net margin of 32.51%. The firm had revenue of $134.29 million during the quarter, compared to the consensus estimate of $128.87 million. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.06). Automated workflows for 5' multiomic profiling of single cell gene expression and cell surface protein are also available.10x Genomics ( NASDAQ:TXG – Get Free Report) last issued its earnings results on Wednesday, May 3rd. With Automation for Single Cell Immune Profiling workflows, you can automate your 5’ gene expression and V(D)J amplification workflows to examine cellular heterogeneity of the immune system and T- and B-cell receptor diversity, at scale. With Automation for Single Cell Gene Expression, you can automate your 3’ gene expression workflows to explore cellular heterogeneity, discover novel targets and biomarkers, and unravel complex cellular processes, with increased productivity. Take a closer look at Chromium Connect to increase your productivity with automated single cell library preparation from cell or nuclei suspensions or purified cDNA. Run 10x Genomics single cell workflows with walk-away convenience. Additional flexibility is provided through modular workflow options that enable automated library construction starting from cDNA manually generated on the Chromium X/iX or Controller, or on prior Connect runs. Looking for consistent and reproducible single cell results across experiments, across users, and even across multiple sites? With Chromium Connect, you can combine single cell partitioning, barcoding, and library preparation in standardized, automated workflows. Rely on expert on-site instrument installation and remote troubleshooting technical assistance. Go from sample to sequencing-ready libraries in one day, with flexible, modular workflow options. Reduce variability in single cell data, generating reproducible and consistent results.įree up hands-on time for other experiments with walk-away convenience for single cell workflowĪutomate single cell partitioning, barcoding, and library prep with one optimized instrument.Įfficiently characterize single cells with gene expression or multiomic immune profiling.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |